Le Lézard
Classified in: Health
Subject: RCL

DAVINCI LABORATORIES ISSUES ALLERGY ALERT ON UNDECLARED SHELLFISH ALLERGEN IN AMYLOID COMPLETE PRODUCT LOT 549853001


WILLISTON, Vt., May 8, 2024 /PRNewswire/ -- DaVinci Laboratories, a division of FoodScience, LLC of Williston, Vermont is recalling 72 bottles of Amyloid Complete because it may contain undeclared shellfish (Shrimp and Crab). People who have an allergy or severe sensitivity to shellfish run the risk of serious or life-threatening allergic reaction if they consume these products.

Amyloid Complete product was distributed nationwide through e-commerce (iHerb.com, fullscripts.com) and direct delivery.

Product is contained in a white plastic bottle marked with lot # 549853001 and 0125 expiration date on the side of the label. Amyloid Complete is a capsule that is tan in color.

The issue was identified through a customer complaint which found bottles of Amyloid Complete may contain Perna Plus Tabs with DMG, resulting in undeclared shellfish. No illnesses have been reported to date.

Consumers who are allergic or sensitive to shellfish should not consume this product. Consumers who have purchased DaVinci Laboratories Amyloid Complete Product containing this lot number are urged to contact the company at 1-800-325-1776 M-F 8:30am-5:00pm EST to arrange for return and replacement of product.

Beth Bartlett/1-800-325-1776

DaVinci Laboratories, a division of FoodScience, LLC
929 Harvest Lane
Williston, Vermont 05495

Amyloid Complete Label

SOURCE FoodScience, LLC


These press releases may also interest you

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 12:18
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...



News published on and distributed by: